TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -0 | 4 | 12 | 7 | 5 | 1 | 5 |
| S | %wins | 75 | 50 | 25 | 50 | 50 | 50 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/09 15:50 | 5/7/09 | BRKR | Bruker Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Laukien Marc M | FL | T | S | -14,508 | 6.91 | 4 | -2,100 | -13 | 14,506 | D | -11 | -37 | 41 | 68 | 26 | 9 | 18 | 5 | -3 | -11 | 5 | 35 | 43 | 74 | |
2/28/08 14:19 | 2/26/08 | BRKR | Bruker Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Laukien Marc M | FL | T | S | -17,151 | 9.14 | 5 | -1,876 | -10 | 16,606 | D | 162 | 36 | 70 | 39 | 6 | 23 | 27 | 17 | 5 | 23 | 28 | -2 | 18 | -66 | |
2/14/07 11:26 | 2/12/07 | BRKR | Bruker Biosciences Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Laukien Marc M | FL | T | S | -21,229 | 7.10 | 3 | -2,990 | -28 | 7,693 | D | 97 | 76 | 33 | 3 | 6 | 6 | 6 | 0 | -2 | 4 | 22 | 15 | -6 | 35 | |
4/29/04 14:24 | 4/28/04 | BRKR | Bruker Biosciences Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Laukien Marc M | FL | T | S | -17,250 | 4.50 | 2 | -3,833 | -29 | 9,363 | D | -33 | 60 | 13 | -12 | 0 | 1 | 8 | 0 | -1 | -2 | -8 | -21 | -37 | -40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |